OVIDE-HENRI BERNADOTTE: Open Payments
NPI 1598777294 · CLEWISTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 120 payments from 14 companies in 2025. Trend: 2023 $1,856 · 2024 $1,683 · 2025 $2,023
Food & beverage: $2,018Education: $5
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $360 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $301 |
| Supernus Pharmaceuticals, Inc. | 37 | $227 |
| Otsuka America Pharmaceutical, Inc. | 8 | $211 |
| Collegium Pharmaceutical, Inc. | 6 | $198 |
| Janssen Pharmaceuticals, Inc | 9 | $182 |
| E.R. Squibb & Sons, L.L.C. | 10 | $172 |
| ABBVIE INC. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 5 | $84 |
| Tris Pharma Inc | 3 | $55 |
Products named: INGREZZA, CAPLYTA, Qelbree, Jornay PM, ABILIFY MAINTENA, INVEGA SUSTENNA, COBENFY, VRAYLAR.
Industry payments across FL — which companies pay providers there.
